Financials data is unavailable for this security.
Cash flow in SEKView more
In 2023, cash reserves at Annexin Pharmaceuticals AB (publ) fell by 9.70m. Cash Flow from Financing totalled 33.61m or -- of revenues. In addition the company used 43.40m for operations while cash from investing totalled 96.00k.
Cash flow per share | -0.1727 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0676 |
---|---|
Tangible book value per share | 0.067 |
More ▼
Balance sheet in SEKView more
Current ratio | 7.39 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼